The CD56 antigen is normally expressed on natural-killer cells but has additionally been
shown to be present on a variety of hematologic malignancies, including a subset of acute …

Abstract CD56 antigen, a 200–220 kDa cell surface glycoprotein, identified as an isoform of
the neural adhesion molecules (NCAM), has been found frequently expressed in several …

The mechanisms of extramedullary leukemic infiltration are not well characterized. The cell-
surface glycoprotein CD56, which is identical to the neural cell adhesion molecule, may be …

We investigated the expression of CD56 (a neural cell adhesion molecule, NCAM) and
CD57 in various hematopoietic and non-hematopoietic malignant cells, using Leu-19 and …

BACKGROUND AND OBJECTIVES. CD56 antigen expression has been reported in several
hematologic malignancies. In acute myeloid leukemia (AML) M2 with t (8; 21) and acute …

CD56 is a natural killer (NK) cell marker that has been identified in approximately 15–20% of
acute myeloid leukemia (AML) cases, where it has been associated with monocytic …

The neural cell adhesion molecule, CD56, is expressed on acute myelogenous leukemia
(AML) cells in 17–20% of the patients. However, the clinical and biological significance of its …

CD56, a neural adhesion molecule, is a marker of natural killer (NK) lymphocytes as well as
a subgroup of CD8+ T cells. Normal lymphocytes with a CD56/CD4 phenotype are scarce …

We examined the pre-treatment bone marrow samples from 200 consecutive adult patients
with acute lymphoblastic leukemia (ALL) treated on various protocols at the University of …

We report a case of acute myeloid leukemia which we have classified as acute
megakaryoblastic leukemia because of intracytoplasmic expression of CD61. Light …